Hamad A
RSC Adv. 2023; 13(14):9361-9369.
PMID: 36959881
PMC: 10029856.
DOI: 10.1039/d2ra08183k.
Vandamme T, Demoustier M, Rollmann B
Eur J Drug Metab Pharmacokinet. 1995; 20(2):145-9.
PMID: 8582440
DOI: 10.1007/BF03226369.
Rousseau F, Haguenoer J, Lesieur D, Gamot A
Eur J Drug Metab Pharmacokinet. 1981; 6(4):281-8.
PMID: 7333328
DOI: 10.1007/BF03189527.
Luyckx M, Rousseau F, Cazin M, Brunet C, CAZIN J, Haguenoer J
Eur J Drug Metab Pharmacokinet. 1982; 7(4):247-54.
PMID: 7166176
DOI: 10.1007/BF03189626.
Renoux G
Drugs. 1980; 20(2):89-99.
PMID: 6995097
DOI: 10.2165/00003495-198020020-00001.
Immunostimulation. Clinical and experimental perspectives.
Drews J
Klin Wochenschr. 1984; 62(6):254-64.
PMID: 6716911
DOI: 10.1007/BF01721886.
Levamisole in postoperative adjuvant immunochemotherapy for gastric cancer. A randomized controlled study of the MMC + Tegafur regimen with or without levamisole. Report I.
Niimoto M, Hattori T, Ito I, Tamada R, Inokuchi K, Orita K
Cancer Immunol Immunother. 1984; 18(1):13-8.
PMID: 6435856
PMC: 11039146.
DOI: 10.1007/BF00205393.
Effects of Levamisole in adjuvant immunochemotherapy for gastric cancer; a prospective randomized controlled study.
Hattori T, Niimoto M, Toge T, Oride M, Nakao A, Yoshinaka K
Jpn J Surg. 1983; 13(6):480-5.
PMID: 6423870
DOI: 10.1007/BF02469490.
Radio-chemo-immunotherapy (CCNU plus levamisole) for treatment of metastatic brain tumors. A pilot study.
Cuna G, Pavesi L, Knerich R, Preti P, Paoletti P
J Neurooncol. 1984; 2(3):237-40.
PMID: 6334142
DOI: 10.1007/BF00253275.
Levamisole does not affect the virological and serological responses of bovine leukemia virus-infected cattle and sheep.
Van Der Maaten M, Schmerr M, Miller J, Sacks J
Can J Comp Med. 1983; 47(4):474-9.
PMID: 6321003
PMC: 1235979.
The experimental and clinical use of immune-modulating drugs in the prophylaxis and treatment of infections.
Drews J
Infection. 1984; 12(2):157-66.
PMID: 6203843
DOI: 10.1007/BF01641705.
Effect of levamisol on cellular and humoral immune reactivity and on recurrences in patients with bladder papilloma.
Romics I, Horvath J, Feher J, CSONTAI A
Int Urol Nephrol. 1985; 17(4):323-30.
PMID: 3835174
DOI: 10.1007/BF02083502.
The experimental and clinical use of immune-modulating drugs in the prophylaxis and treatment of infections.
Drews J
Infection. 1985; 13 Suppl 2:S241-50.
PMID: 2414227
DOI: 10.1007/BF01644438.
Effect of rat and beta-human interferons on hyperacute experimental allergic encephalomyelitis in rats.
Hertz F, Deghenghi R
Agents Actions. 1985; 16(5):397-403.
PMID: 2413742
DOI: 10.1007/BF01982879.
Four year double-blind controlled study of levamisole in multiple sclerosis.
Massaro A, Cioffi R, Laudisio A, Schiavino D, Mariani M
Ital J Neurol Sci. 1990; 11(6):595-9.
PMID: 2081685
DOI: 10.1007/BF02337444.
Adjuvant therapy for colorectal carcinoma.
Metzger U
World J Surg. 1991; 15(5):576-82.
PMID: 1949854
DOI: 10.1007/BF01789201.
Levamisole treatment of local and metastatic growth of transplanted rat tumours.
Hopper D, Pimm M, Baldwin R
Br J Cancer. 1975; 32(3):345-51.
PMID: 1233079
PMC: 2024738.
DOI: 10.1038/bjc.1975.233.
Enhanced resistance to Corynebacterium pseudotuberculosis infections associated with reduced serum immunoglobulin levels in levamisole-treated mice.
Irwin M, Knight H
Infect Immun. 1975; 12(5):1098-103.
PMID: 1193726
PMC: 415403.
DOI: 10.1128/iai.12.5.1098-1103.1975.
In vitro stimulation of murine lymphoid cell cultures by levamisole.
Merluzzi V, Badger A, Kaiser C, COOPERBAND S
Clin Exp Immunol. 1975; 22(3):486-92.
PMID: 1083786
PMC: 1538428.
Adjuvant treatment of colorectal cancer.
Nystrom J, Bateman J, Weiner J
West J Med. 1977; 126(2):95-101.
PMID: 847983
PMC: 1237465.
